China's Kintor Pharma falls most in 11 weeks on wider H1 loss

Kintor Pharmaceutical

30/08/2022 04:59

** Shares of Chinese drug developer Kintor Pharmaceutical
Ltd  9939.HK  fall as much as 8.8% to HK$17.06, the biggest
daily pct decline since June 13 if losses hold
    ** Stock is the fourth-biggest pct decliner in Hang Seng
Composite Index  .HSCI  
    ** Jiangsu-based company says H1 adjusted loss widended to
468.6 mln yuan ($67.75 mln) from 299.9 mln yuan loss the same
period in 2021 with R&D cost up 63.4% from a year ago period to
461.1 mln yuan  urn:newsml:reuters.com:*:nFWN3050OT
    ** Hang Seng Commerce & Industry Index  .HSNC  falls 1.1%
and healthcare index  .HSCIH  drops 1.9%
    ** Hang Seng Composite Index  .HSCI  and Hang Seng Index
 .HSI  both slip 0.9%

($1 = 6.9171 Chinese yuan renminbi)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))